Location History:
- Boston, MA (US) (1993)
- Malden, MA (US) (1996)
- Georgetown, MA (US) (2009 - 2012)
Company Filing History:
Years Active: 1993-2012
Title: Todd Blythe: Innovator in Pharmaceutical Chemistry
Introduction
Todd Blythe is a notable inventor based in Georgetown, MA (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of seven patents, showcasing his innovative approach to drug development and formulation.
Latest Patents
Among his latest patents is the invention related to polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate. This invention encompasses various polymorphic forms, processes for their preparation, pharmaceutical compositions, and their uses. Another significant patent involves polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate, which also includes processes for preparation and pharmaceutical applications.
Career Highlights
Todd Blythe is currently employed at Vertex Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His work has significantly impacted the field, particularly in the area of drug formulation.
Collaborations
He has collaborated with esteemed colleagues such as Philip L. Nyce and John R. Snoonian, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Todd Blythe's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic solutions.